|
|
רופא/ה נכבד/ה, הנך מוזמן/ת לאולפן בשידור חי:
|
|
Kidney protection by SGLT2 inhbitors: from pathophysiology to real life
|
|
|
|
|
|
Moderator: Dr. Ofri Mosenzon
|
Hadassah Diabetes Unit, Department of Endocrinology, Jerusalem
|
|
|
|
|
|
The present and future of treatment with SGLT2i in diabetic and non-diabetic kidney disease: lessons from DAPA-CKD and beyond
|
|
Prof. Hiddo L. Heerspink, PhD, PharmD
|
University Medical Center Groningen, Netherlands
|
|
|
|
|
|
Novel mechanisms of kidney protection by SGLT2 inhibitors in diabeic kidney disease and acute kidney injury
|
Hadassah Diabetes Unit, Department of Endocrinology, Jerusalam, Head of the israel Endocrine Society
|
|
|
|
|
|
|
|
|
|
|
|
|
|
